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Abstract 
Reactive oxygen species (ROS) decreases bioavailability of nitric oxide (NO) and impairs NO-
dependent relaxations. Like NO, hydrogen sulfide (H2S) is an antioxidant and vasodilator; however, the 
effect of ROS on H2S-induced relaxations is unknown. Here we investigated whether ROS altered the 
effect of H2S on vascular tone in mouse aorta and determined whether resveratrol (RVT) protects it via 
H2S. Pyrogallol induced ROS formation. It also decreased H2S formation and relaxation induced by L-
cysteine and in mouse aorta. Pyrogallol did not alter sodium hydrogensulfide (NaHS)-induced 
relaxation suggesting that the pyrogallol effect on L-cysteine relaxations was due to endogenous H2S 
formation. RVT inhibited ROS formation, enhanced L-cysteine-induced relaxations and increased H2S 
level in aortas exposed to pyrogallol suggesting that RVT protects against “H2S-dysfunctions” by 
inducing H2S formation. Indeed, H2S synthesis inhibitor AOAA inhibited the protective effects of 
RVT. RVT had no effect on Ach-induced relaxation that is NO dependent and the stimulatory effect of 
RVT on H2S-dependent relaxation was also independent of NO. These results demonstrate that 
oxidative stress impairs endogenous H2S-induced relaxations and RVT offers protection by inducing 
H2S suggesting that targeting endogenous H2S pathway may prevent vascular dysfunctions associated 
by oxidative stress. 
 
Keyword: Oxidative Stress, Resveratrol, Hydrogen Sulfide, Aorta, Relaxation 
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Introduction 
 
Atherosclerosis, hypertension, diabetes mellitus and even preeclampsia are all associated with 
increased reactive oxygen species (ROS) [1]. Nitric oxide (NO) protects against myocardial infarction 
[2; 3] and ROS decreases bioavailability of NO. Hydrogen sulfide (H2S) also possesses cardiovascular 
protective properties. Levels of H2S is decreased in aging [4], hyperglycaemia [5; 6], diabetes [7] and 
preeclampsia [8]. The enzymes responsible for the generation of endogenous H2S include 
cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and mitochondrial 3-mercaptopyruvate 
sulfurtransferase (3MPST). The production of H2S through the MPST pathway is decreased by pro-
oxidant H2O2 in vitro [6], however the role of oxidants on H2S formation and vasorelaxation induced 
by L-cysteine is unknown. The aim of this study was to investigate the effects of oxidative stress 
induced by pyrogallol on H2S-induced relaxation in mouse aorta.  
 
The antioxidant Resveratrol (RVT), a polyphenol present in red wine, offers protection in vascular 
pathologies such as diabetes, erectile dysfunction, hypertension and metabolic syndrome [9] and 
preeclampsia [10]. Interestingly, the beneficial effect of RVT is attributed to activation of eNOS and 
inhibition of NADPH oxidase [11; 12] via SIRT [12; 13] in vascular system. Hydrogen sulfide 
activates eNOS [14; 15] and SIRT [16] and inhibits NADPH oxidase [17; 18; 19]. Also nuclear factor 
erythroid 2-related factor 2 (Nrf-2) is enrolled in the antioxidant effect of both RVT [20] and H2S [7; 
21; 22]. These common links led us to further investigate the role of H2S in the protective effects of 
RVT in vascular oxidative stress in the regulation of vascular tone and ROS formation in mouse aorta.  
 
Method 
Animals 
The present study was approved by the Animal Experiment Local Ethical Committee of Ege University 
(No: 2015-070) in agreement with European guidelines for animal care. All experiments were 
conducted on 10 to 12 weeks of age male CD1 mice (n=50) obtained from the Breeding Center of 
Experimental Animals in Ege University (ARGEFAR). The animals were stunned by inhalation of 
CO2, sacrificed by decapitation and exsanguinated.  
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Drugs and treatments 
For ROS/H2S formation, isolated aortic rings in HEPES buffer or homogenates in phosphate buffer 
were incubated respectively with either cystathionine gamma lyase/cystathionine beta synthase 
(CSE/CBS) inhibitor (AOAA, 2 mM), CSE inhibitor PAG (10 mM) or the eNOS inhibitor L-NNA 
(0.1mM) for 30 minutes Thereafter, without washing, RVT (0.01 mM) was added for 30 min in the 
presence or absence of the inhibitors. Pyrogallol was then added (0.1mM) for 5 min prior to assaying 
(Fig 1). 
The same order of incubation without washing in KREBS Buffer was used for isolated organ bath 
experiments to get dose response curves after confirmation of the presence of the endothelium. In some 
experiments to measure H2S or ROS level, NAHS (1mM) was added to the homogenates or isolated 
aortic rings for 10 minutes followed by pyrogallol for 5 min without washing. 
 
 
Fig. 1 Protocol for the treatments used in the study  
RVT were acquired from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Unless otherwise stated, 
all other chemicals were obtained from Sigma. 
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Measurement of reactive oxygen species formation by chemiluminescence 
Luminol and lucigenin chemiluminescences was measured as indicators of ROS formation according to 
the modified method described by Munzel et al [23]. The assay was performed with aortic rings in 1 ml 
HEPES-buffered physiological solution (pH 7.4). After incubations with pharmacological agents as 
given above lucigenin or luminol (5 μmol/L) were added to measure ROS level. This lower 
concentration of lucigenin was demonstrated not to be involved in redox cycling and to specifically 
indicate superoxide anion levels in intact vascular tissue. ROS were quantified using a multi-plate 
reader (Varioskan 
TM
 Flash multimode reader, Thermo Scientific, USA). Luminol detects a group of 
reactive species, i.e., .OH, H2O2, HOCl, and lucigenin is selective for O2-  [24]. Counts were obtained 
at 1 min intervals for a counting period of 5 min. and the results were given as the area under the curve 
(AUC) of relative light units (rlu)/mg of wet tissue. 
 
Isolated organ bath experiments 
The aorta was isolated and cut into two 4 mm-long rings after removal of loose connective tissue. The 
individual aortic rings were separated, mounted in 5 ml organ bath of DMT 610 ring myograph for 
isometric force recording (Danish Myograph Technology, Aarhus, Denmark) coupled to a PowerLab 
8/SP data acquisition system (Chart 5.0 software; ADInstruments, Colorado Springs, CO) and bathed 
in carboxygenated (95% O2; 5% CO2) modified Krebs–Ringer solution NaCl, 130 mM; NaHCO3, 14.9 
mM; dextrose, 5.5 mM; KCl, 4.7 mM; KH2PO4, 1.18 mM; MgSO47H2O, 1.17 mM and CaCl2.2H2O, 
1.6 mM) at 37 °C. Tissues were allowed to equilibrate for 90 min. under a resting tension of 20 mN. 
Experiments were done in rings with endothelium as confirmed by relaxation more than 40 % to ACh 
(1 μM) after contraction with phenylephrine (Phe, 10 μM). One concentration-response curve was 
obtained in each ring. After confirmation of presence of the endothelium, relaxant responses to either 
ACh (10
-9
-10
-4
 M) or exogenous H2S donor NaHS (10
-6
-3.10
-2
 M) or endogenous H2S donor L-cysteine 
(10-20-40-80 mM) was obtained after pre-contraction by phenylephrine. The concentration of 
phenylephrine is altered in some vessels to get equal pre-contraction. Aortic rings were exposed to 
pyrogallol to induce oxidative stress.  
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Measurement of H2S level by Methylene blue assay 
To assess H2S formation by CSE/CBS pathway in aorta, H2S determination was evaluated according to 
Stipanuk and Beck [25]. Since the mouse aorta is thin and small, at least 3-4 mice aorta were 
combined, homogenized with lysis buffer. After incubation with pharmacological agents as given 
above, the same protocol with our previous study was used to measure H2S formation in aortic 
homogenates [26]. The optical absorbance of the resulting solution was measured after 10 min. at a 
wavelength of 650 nm.  All samples were assayed in duplicate. The absorbance values obtained in the 
absence of homogenates under different treatments were subtracted from reel absorbance to get net 
absorbance to calculate H2S concentration in samples against a calibration curve of NaHS (3.9–
250 µM). Data were calculated as nmol per milligram of protein.min-1. 
 
Statistics 
Data are expressed as % relaxation of the Phe-induced tone. Concentration–response curves were fitted 
by sigmoid curves using the least squares method. All calculations were determined using a standard 
statistical software package (Prism5, Graphpad, San Diego, California, USA). Significance was 
accepted at p<0.05. The data were computed as means ± SEM and evaluated statistically using the 
One-Way ANOVA or Two-Way ANOVA when appropriate. If there is an interaction between 
concentrations and treatments Bonferroni post hoc test were used after ANOVA. “n” is the number of 
tissues. 
 
RESULTS 
 
Reactive oxygen species  
Pyrogallol treatment (0.1 mM, 5 min.) induced both superoxide and other reactive oxygen species 
(ROS) generation in mouse aorta (Figure 2a and 2b, respectively, p<0.01, One-Way ANOVA, 
Bonferroni post hoc test, n=6). Both RVT (0.01 mM, 30 min.) and exogenous H2S donor NaHS 
significantly inhibited ROS generation (Figure 2a and 2b, p<0.01, p<0.05, respectively, One-Way 
ANOVA, Bonferroni post hoc test, n=7). CBS and CSE inhibitor AOAA or the CSE inhibitor PAG 
completely reversed the antioxidant effect of RVT (Figure 2a and b, p<0.05, One-Way Anova, 
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Bonferroni post hoc test, n=7). However eNOS inhibitor L-NNA did not alter RVT-induced inhibition 
of superoxide or other ROS formation significantly. 
 
 
A 
 
B 
Fig. 2 The effects of RVT on A) superoxide B) other reactive oxygen species induced by 
pyrogallol in mouse aorta  
Pyrogallol (0.1mM) increased superoxide (O2
-
) and ROS generation, as measured by lucigenin and 
luminol assay, respectively. RVT (0.01 mM) or NaHS (1mM) significantly inhibited O2
- 
and ROS 
formation induced by pyrogallol. H2S inhibitor AOAA (2 mM) or PAG (10 mM), reversed these 
effects significantly. Although there is a trend, L-NNA (0.1mM) could not reverse the antioxidant 
effect of RVT significantly. **p<0.01,***p<0,001 compared to control, ++ p<0.01, +++ p<0.001, 
compared to pyrogallol (PYR), # p<0.05 compared to pyrogallol+resveratrol (PYR+RVT), One-Way 
Anova, n=7.  
 
ACh relaxations  
ACh caused relaxation in the mouse aorta in a concentration-dependent manner. Pyrogallol decreased 
the ACh-induced relaxation (Figure 3, p<0.05, compared to control, Two-Way ANOVA, n=5). RVT 
(0.01 mM, 30 min.) did not alter NO-dependent relaxations in normal conditions or in the presence of 
oxidative stress (Figure 3, Two way Anova, n=5).  Pyrogallol reduced pD2 values significantly (Table 
1, p<0.01, One way Anova, n=5) and tends to decrease maximal relaxation to ACh however it did not 
reach a significant level.  RVT did not alter pyrogallol-induced decrease in pD2 values or tendency to 
reduced maximal relaxation to ACh 
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Fig. 3 The effect of RVT on ACh relaxation in pyrogallol-induced oxidative stress in mouse aorta  
Pyrogallol (0.1mM) slightly decreased ACh relaxations in mouse aorta. RVT (0.01 mM) did not alter 
NO-dependent relaxations in normal conditions but restored impaired relaxations in the presence of 
pyrogallol-induced oxidative stress. *p<0.05, control vs. pyrogallol, Two-Way Anova, n=5.  
 
 CONT PYR RVT RVT+PYR 
pD2 for ACh 6.921 ±0.256 6.791±0.329 ** 7.131±0.122 6.996±0.212 
EMax for ACh 50.10±5.876 39.79±7.174 46.02±6.996 42.52±8.539 
 
Table 1 The effect of RVT on pD2 values and maximal relaxation of ACh relaxation in the 
presence or absence of pyrogallol-induced oxidative stress in mouse aorta. Pyrogallol (0.1mM) 
significantly decreased pD2 values without changing maximal relaxation to ACh relaxations in mouse 
aorta. RVT (0.01 mM) did not alter maximal relaxations or pD2 values. **p<0.01, control vs. 
pyrogallol, One-Way Anova, n=5.  
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L-cysteine relaxations 
L-cysteine caused a concentration dependent slight contraction at the very first concentrations and then 
relaxation in mouse aorta. Endogenous H2S-relaxation was significantly diminished in the presence of 
oxidative stress (Figure 5, p<0.001, Two-Way Anova, n=9-6, respectively). Despite, RVT (0.01 mM, 
30 min.) enhanced relaxation to L-cysteine and this effect was inhibited by the CSE inhibitor PAG or 
CBS/CSE inhibitor AOAA at the same rate but not by eNOS inhibitor L-NNA significantly (Figure 4 
, p<0.001 compared to control and p<0.001, compared to RVT, Two-Way Anova, n=5-11).  
 
 
 
Fig. 4 The effect of RVT on L-cysteine induced relaxations in mouse aorta 
RVT (0.01 mM) increased L-cysteine relaxation significantly. This effect of RVT were inhibited by 
CBS/CSE inhibitor AOAA (2 mM) or the CSE inhibitor PAG (10 mM) significantly but not by eNOS 
inhibitor L-NNA (0.1mM).  *** p<0.001 compared to control (CONT), +++ p<0.001 compared to 
resveratrol (RVT), Two Way Anova, n=5-11.  
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The stimulatory effect of RVT was still dominant under oxidative stress. Since both PAG and AOAA 
inhibited RVT-induced augmentation of L-cysteine relaxation, the effect of PAG as CSE inhibitor has 
been tested to investigate the role of H2S in the effect of RVT to restore impaired relaxation to L-
cysteine under oxidative stress. RVT could not rescue disrupted endogenous H2S-dependent relaxations 
when H2S synthesis is inhibited by PAG, suggesting H2S was enrolled in the protective effect of RVT 
under oxidative stress (Figure 5, p<0.001, compared to PYR, p<0.05 compared to PYR+RVT, Two-
Way Anova n=5, respectively).  
  
 
 
Fig. 5 The effect of resveratrol on L-cysteine induced relaxations in the presence of pyrogallol-
induced oxidative stress in mouse aorta  
Pyrogallol (0.1mM) decreased L-cysteine relaxation significantly. RVT (0.01 mM) restored the 
diminished endogenous H2S-dependent relaxations in oxidative stress. H2S synthesis inhibitor PAG  
(10 mM) inhibited RVT-induced protection on L-cysteine relaxations. ***p<0.001 compared to control 
(CONT), +++p<0.001, compared to Pyrogallol (PYR), ψ p<0.05 compared to pyrogallol+resveratrol 
(PYR+RVT) Two Way Anova, n=5-9. 
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NaHS relaxations  
Alterations in downstream mechanisms of H2S were tested in response to the exogenous H2S donor 
(NaHS). NaHS caused a concentration-dependent relaxation in the mouse aorta. Pyrogallol-induced 
oxidative stress did not alter relaxation to NaHS (Figure 6, p>0.05, compared to control, Two-Way 
Anova, n=5).  
 
 
Fig. 6 The effect of pyrogallol on NaHS induced relaxations in mouse aorta  
Exogenous H2S donor NaHS induced concentration dependent relaxation in mouse aorta. Pyrogallol 
(0.1mM) did not significantly change exogenous H2S dependent relaxations. p>0.05 compared to 
control (CONT), Two-Way Anova, n=5. 
 
H2S formation 
H2S formation in mouse aortic rings was measured by methylene blue assay, to investigate if oxidative 
stress alters H2S formation and the role of H2S in the protective effect of RVT under oxidative stress, 
RVT incubation caused a significant increase in H2S levels in both basal and L-cysteine stimulated 
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conditions.  RVT-induced augmentation of H2S level was inhibited by AOAA.  Pyrogallol decreased 
L-cysteine-stimulated H2S formation significantly. (Figure 7, p<0.001, One-Way Anova, n=7). RVT 
reversed this impaired H2S formation in the presence of oxidative stress (Figure 7, p<0.01, One-Way 
Anova, n=7).   
 
 
Fig. 7 The effect of RVT and oxidative stress on H2S formation in mouse aorta 
RVT (0.01 mM) significantly increased basal H2S formation in the presence or absence of oxidative 
stress and this stimulatory effect was reversed by H2S synthesis inhibitor AOAA (2 mM). Pyrogallol 
(0.1mM) decreased the L-cysteine (10 mM) stimulated H2S formation and RVT restored it slightly. 
***p<0.001, compared to control (CONT), +++p<0.001 compared to RVT, # p<0.05, ## p<0.001 
compared to pyrogallol (PYR), ∴ p<0.01 compared to pyrogallol+resveratrol (PYR +RVT).  One-Way 
ANOVA, n=7.  
 
Discussion 
This study shows that ROS generated by pyrogallol significantly decreases H2S formation, which 
resulted in disruption to the endogenous H2S-dependent relaxations. Furthermore, the antioxidant effect 
of RVT requires H2S but not NO. RVT stimulates H2S formation through the CBS/CSE pathways and 
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restores impaired endogenous H2S-dependent relaxations in the presence of oxidative stress. These 
results support the therapeutic value of RVT and demonstrate significance of H2S dysfunction in 
vascular oxidative stress. 
 
Oxidative stress inhibits NO bioavailability, which is accepted as the main cause of endothelial 
dysfunction and cardiovascular diseases. H2S have some similarities to NO to provide protection for 
cardiovascular system as a vasodilator, antioxidant, anti-inflammatory gasotransmitter, depends on 
concentration as in NO. There are accumulated evidence showing impaired H2S level in 
hyperglycaemia [27], diabetes [28] [29], atherosclerosis [30] and hypercholesterolemia [3] where 
oxidative stress is accompanied. Although a recent study shows acute oxidative stress by H2O2 causes a 
decrease in MPST-induced H2S formation [6], there is no study investigating the role of vascular 
oxidative stress on the CSE/H2S -dependent regulation of ROS formation and vascular tonus yet. We 
found that pyrogallol causes both superoxide radical and other ROS formation (Figure 2a and 1b) and 
oxidative stress induced by pyrogallol significantly decreases L-cysteine stimulated endogenous H2S 
formation without altering basal H2S formation in mouse aorta (Figure 7). To our knowledge this is the 
first study reporting impaired L-cysteine induced H2S formation and relaxation in oxidative stress. 
Several studies showed that L-cysteine, the substrate of CSE and CBS, induces relaxations through 
H2S, since CBS/CSE inhibitor AOAA [31] or CSE inhibitor PAG [32]  inhibits this relaxation in 
bladder [33] corpus cavernosum [26; 34] as well as aorta [31] [35]. In our study, L-cysteine caused a 
relaxation in mouse aorta (Figure 4 and 5) confirming previous studies [35; 36].  The major findings of 
our study showed that acute oxidative stress inhibits endogenous H2S-dependent relaxation induced by 
L-cysteine (Figure 5). Further we found that the impairment in L-cysteine-induced relaxation was not 
depending on downstream mechanism of vasorelaxation through H2S, since exogenous H2S donor 
NaHS-induced relaxations were not decreased by oxidative stress (Figure 6).  Thus we conclude that 
disrupted L-cysteine induced relaxation in oxidative stress was dependent on decreased endogenous 
H2S formation. These data suggest that decreased H2S may contribute to the regulation of vascular 
tonus in cardiovascular disease where oxidative stress accompanies. 
 
H2S-targeting treatments have protective effects in endothelial dysfunctions [3] including diabetes [27], 
myocardial infarction [37], myocardial ischemia/reperfusion [38], hypertension [39], atherosclerosis 
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[29; 30] and erectile dysfunction [40]. Interestingly RVT is also protective in these cardiovascular 
diseases [41]. RVT and H2S share some mechanisms such as SIRT activation, PDE inhibition and 
KATP activation. Recently we have showed RVT induce H2S formation in penile tissue [26].  These 
observations had led us to investigate whether H2S contribute to the beneficial effect of RVT in aorta. 
RVT induced CSE/CBS dependent H2S formation in mouse aorta in the presence or absence of 
oxidative stress (Figure 7), suggesting the effect of RVT on H2S formation was not limited to 
pathological conditions or penile tissue.  Beside RVT enhanced the endogenous H2S dependent 
relaxation (Figure 4) via promoting H2S formation in mouse aorta as in mouse corpus cavernosum 
(MCC) [26]. We now further showed that CBS/CSE inhibitor AOAA or the CSE inhibitor PAG 
reversed the augmentation of L-cysteine relaxations in mouse aorta in a same rate (Figure 4), 
emphasize the role of CSE/H2S pathway rather than CBS in protective effect of RVT. Further this 
effect was not returned by eNOS inhibitor L-NNA in mouse aorta as in MCC [26], suggesting NO-
independent regulation of endogenous H2S-relaxation by RVT.  Although vascular protective effects of 
RVT have been mostly attributed to eNOS activation [42; 43; 44; 45], we showed in this study that 
RVT also protects impaired endogenous H2S dependent relaxations under oxidative stress. CSE/H2S 
pathway contributes to the protective effect of RVT, since PAG reversed the enhanced relaxation to L-
cysteine by RVT (Figure 4). We should note that although the inhibition rate by PAG was around 56%, 
but still it was not complete. The reason for not full inhibition may result from the activation of H2S 
formation by RVT and a counterbalance effect of PAG to inhibit H2S formation. Alternatively this 
could be due to a lack of efficacy of PAG in inhibiting CBS/CSE or the contribution of an additional 
enzyme (MPST) or additional mechanisms.  However the contribution of the third enzyme MPST to 
RVT-induced H2S synthesis and relaxation could not be determined, since there are no specific 
inhibitors of MPST. On the other side oxidative stress depressed endogenous H2S induced relaxation 
more than NO-dependent relaxations in mouse aorta (Figure 5 and 3, respectively). Impaired relaxation 
to ACh was not restored by RVT in mouse aorta (Figure 3). However improvement of endothelial 
relaxations by chronic RVT treatment in aorta from spontaneous hypertensive conditions but not 
normotensive conditions was reported in rat [46]. This discrepancy may result from differences 
between pathological conditions or species. Nevertheless the protective effect of RVT on L-cysteine 
relaxation was much more pronounced than from ACh-induced relaxations.  
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H2S have also significant role in vessels via regulating ROS formation, which is an important 
signalling molecule in inflammation, apoptosis and proliferation processes that ultimately regulate 
vascular disease such as atherosclerosis. Interestingly recent studies revealed that SIRT activation is 
linked to NADPH inhibition [12] and RVT as a known SIRT activator [13] have a capacity to inhibit 
NADPH [11] in vascular system as in reported by H2S [17; 19]. Beside other antioxidant mechanisms 
of RVT and H2S are similar such as activation of eNOS [1] [14], SOD [47] [48] and HO-1 [10; 49] as 
well as Nrf-2 translocation [50] [7]. Because of these similarities we investigated the role of H2S in the 
antioxidant effect of RVT in mouse aorta. RVT (0.1 mM, 30 min) significantly inhibited superoxide 
radicals and other ROS formation induced by pyrogallol in mouse aorta (Figure 2) as NaHS (1 mM, 10 
min.) did. H2S synthesis inhibitor AOAA or PAG completely reversed it significantly, showing a 
strong role of H2S pathway in antioxidant effect of RVT (Figure 2). Since inhibition of CSE alone or 
together with CBS did reverse the effect of RVT on superoxide formation at same level, we suggest 
that CSE is involved in these effects rather than CBS. Supporting this, it was reported that CSE 
overexpression inhibits ROS formation and restores impaired ACh-relaxations due to high glucose in 
mouse aorta, whereas CSE inhibition causes an augmentation in mitochondrial ROS formation [27]. 
On the other hand, in our study L-NNA could not cause a significant decrease in antioxidant effect of 
RVT, suggesting pronounced effect of H2S pathway on the effects of antioxidants. Thus we suggest 
that H2S may contribute as an upstream mechanism of protective effect of RVT in oxidative stress. 
 
We should note that the effect of RVT on ROS formation, endogenous H2S dependent relaxation or 
H2S level was returned by AOAA or PAG partly but not completely. This could be due to the 
contribution of 3-mercaptopyruvate sulphurtransferase (MPST), the third enzyme that enrolled in H2S 
formation as well as CBS and CSE, since AOAA is a CBS/CSE inhibitor but a specific 
pharmacological inhibitor of MPST is not known yet. Moreover Czabo et al. already showed that H2S 
production through MPST pathway is reduced in H2O2 induced oxidative stress [6].  
 
Conclusion 
In summary, as PAG or AOAA decreased the effect of RVT on inducing H2S formation and inhibiting 
ROS formation as well as l-cysteine-induced relaxation, we suggest that CSE/H2S pathway can 
contribute to the beneficial effect of RVT under oxidative stress. However we can not rule out the role 
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of other possible mechanisms, since the inhibition of the beneficial effect of RVT by PAG or AOAA 
was not full and we should note that we are suggesting that CSE/H2S pathway may not be the only 
pathway for the beneficial effect of RVT but it contributes to the protective effect of RVT. There are 
already several clinical trials investigating the effect of RVT in cardiovascular diseases in different 
doses. Our study may be important to show the potential of RVT as an H2S-targeting drugs to treat H2S 
pathway related physiological effects in cardiovascular diseases. As H2S requires of smooth muscles 
cells instead of endothelial cell to produce the gasotransmitter to relax the vessel, targeting H2S may be 
a better option in endothelial dysfunctions associated with oxidative stress where NO-dependent 
relaxations is decreased. We conclude that acute oxidative stress impairs H2S dependent protection in 
the aorta. RVT provides protection by limiting ROS formation and promoting vascular relaxation 
through production of H2S under vascular oxidative stress. These data suggest that H2S targeting 
molecules such as RVT may offer an additional supplementation against cardiovascular disease where 
oxidative stress are accompanied with decreased H2S dependent regulation of vascular tone and 
antioxidant systems are impaired. 
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